Latest filing published 03 Feb 2009 for Cellular Biomedicine Group, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
EastBridge Investment Group Corp: trading record in brief
EastBridge Investment Group Corp discloses dealings in Cellular Biomedicine Group, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 20 November 2008 and the latest from 30 December 2008.
Market trades split into 1 purchase (€48k) and 1 sale (€51k). Sales outweigh purchases by €2,684. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2009, the count stands at 1 purchase and 1 sale.
Most recently, on 3 February 2009, the filings show a transaction in Cellular Biomedicine Group, Inc. The latest purchase dates back some time: it was published 6,488 days ago, on 3 February 2009. Filings reach the SEC (Form 4) feed a median of 57 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to EastBridge Investment Group Corp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000,000 shares0Common StockSEC:0001384398-09-000001:0
- 1,500,000 shares@ US$0.04Common StockSEC:0001384398-09-000001:1Canonical exit: 18 Feb 2009 (T+90)
- 1,800,000 shares@ US$0.04Common StockSEC:0001384398-09-000001:2
3 of 3 declarations